brooqLy, Inc. financial data

Symbol
BRQL on OTC
Industry
Services-Computer Processing & Data Preparation
Location
10101 S. Roberts Road, Suite 209, Palos Hills, IL
State of incorporation
Nevada
Fiscal year end
December 31
Former names
MyTreat, Inc. (to 4/1/2021)
Latest financial report
10-Q - Q2 2024 - Aug 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 10.8 % -26.6%
Return On Equity 1.27K %
Return On Assets -397 % -57%
Operating Margin -169K % -1.18%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.4M shares +4.66%
Common Stock, Shares, Outstanding 25.4M shares +7.32%
Entity Public Float 0 USD
Common Stock, Value, Issued 2.54K USD +7.32%
Weighted Average Number of Shares Outstanding, Basic 22.6M shares

Income Statement

Label TTM Value / Value Unit Change %
Revenues 184 USD -16%
Operating Income (Loss) -310K USD +15%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -871K USD -139%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -871K USD -139%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.54K USD -15.1%
Assets, Current 30.2K USD -17.5%
Intangible Assets, Net (Excluding Goodwill) 235K USD
Assets 265K USD +75.5%
Accounts Payable, Current 155K USD +189%
Liabilities, Current 359K USD +173%
Retained Earnings (Accumulated Deficit) -1.52M USD -134%
Stockholders' Equity Attributable to Parent -93.5K USD -571%
Liabilities and Equity 265K USD +75.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21K USD +54.4%
Net Cash Provided by (Used in) Financing Activities 80K USD 0%
Net Cash Provided by (Used in) Investing Activities -58K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 25.4M shares +7.32%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -26.9K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 33 USD -99.5%
Deferred Tax Assets, Valuation Allowance 319K USD -50.9%
Deferred Tax Assets, Operating Loss Carryforwards 319K USD
Additional Paid in Capital 1.42M USD +113%
Amortization of Intangible Assets 150K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 185K USD